Latest Asx Continuous Disclosure News

Sparc Technologies Limited (ASX: SPN) attributes its recent share price increase and trading volume surge to Managing Director Nick O’Loughlin’s participation in a widely listened-to podcast, confirming no undisclosed material information and compliance with ASX Listing Rules.

Earth’s Energy Limited has clarified its ASX disclosures regarding a dispute and subsequent settlement with minority shareholders over its geothermal joint venture, highlighting the evolving nature of the matter and compliance with continuous disclosure rules.

Fiducian Group Limited has responded to a sharp share price drop by denying any undisclosed information and downplaying the impact of new APRA licence conditions on its operations.

PEXA Group has dismissed any undisclosed information behind its recent share price drop, attributing market moves to a preliminary IPART pricing consultation paper.

Advanced Innergy Holdings Ltd has responded to ASX inquiries denying any media leak regarding its proposed $0.40 cash bid for Matrix Composites & Engineering, reaffirming its commitment to strict disclosure policies.

NuEnergy Gas Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, denying any undisclosed material information. The company attributes the surge to positive analyst commentary and heightened investor interest linked to geopolitical tensions.

ADX Energy has responded to ASX inquiries about recent unusual trading activity, confirming no undisclosed information but highlighting a recent placement settlement as a possible factor.

IperionX Limited has denied any undisclosed information following a sharp share price drop from $6.93 to $4.58, clarifying its accounting for U.S. government grants amid market volatility.

WA Kaolin Limited has responded to ASX queries clarifying that its Q2 FY2026 order book was a demand snapshot, not a sales forecast, and confirmed timely disclosure of a production shortfall linked to plant issues. The company also addressed regulatory notices, affirming no material impact on operations or securities value.

Atlas Pearls Ltd has disclosed a significant 27% revenue decline and a net loss for the half year ended December 2025, attributing the results to weaker auction outcomes and one-off accounting impacts. The company affirms timely disclosure and compliance with ASX rules amid market sensitivity.

TZ Limited has responded to ASX queries over the deferral of a A$2.75 million debt repayment, asserting the delay was already well disclosed and unlikely to impact its share price materially.

Cyclopharm Limited has responded to ASX queries clarifying the material significance of its Technegas® contract with the US National Institutes of Health, while confirming robust progress in expanding its US footprint.